Related & Recently Published Reports by Transparency Market Research
In respect to excipients market by type, pregelatinized starch is expected to grow with the highest CAGR of 6.2% from 2013 to 2018 in terms of revenue and in terms of volumes the market for glycerin is growing with the highest CAGR of 6.4% from 2013 to 2018. The growth of gelatins is driven by its growing use in manufacturing drug capsules.
Some of the major players of the market include BASF, DOW, ADM, ABF, FMC, Evonik, Cargill, Proctor and Gamble and Akzonobel.
This research is specially designed to estimate and analyze the demand and performance of excipients in a global scenario. The research provides in-depth analysis of excipients manufacturers, product sales, and trend analysis by segments and demand by geography. The report covers all the major product segments of the excipients market and provides in-depth analysis, historical data and statistically refined forecast for the segments covered. The study presents a comprehensive assessment of the stakeholder strategies, winning imperatives for them by segmenting the excipients market as below:
- Global excipients market, by products
- Ethyl Cellulose
- Methyl Cellulose
- Croscarmellose Sodium
- Pregelatinized Starch
- Sodium Starch Glycolate
- Polyethylene Glycol
- Acrylic Polymers
- Propylene Glycol
- Calcium Phosphate
- Calcium Carbonate
- Silicon Dioxide
- Titanium Dioxide
- Sugar and Other
In addition the report provides cross-sectional analysis of all the above segments with respect to the following geographical markets:
Rest of the World (RoW)
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts